• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植受者发生加速性冠状动脉疾病的危险因素。

Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients.

作者信息

Radovancevic B, Poindexter S, Birovljev S, Velebit V, McAllister H A, Duncan J M, Vega D, Lonquist J, Burnett C M, Frazier O H

机构信息

Cullen Cardiovascular Surgical Research Laboratory, Texas Heart Institute, Houston.

出版信息

Eur J Cardiothorac Surg. 1990;4(6):309-12; discussion 313. doi: 10.1016/1010-7940(90)90207-g.

DOI:10.1016/1010-7940(90)90207-g
PMID:2361019
Abstract

Allograft coronary artery disease (CAD) is the major determinant of long-term survival following heart transplantation (HTx). In a group of 210 heart transplant recipients, we diagnosed CAD in 54 (27.1%) by coronary angiography, postmortem examination or examination of the transplanted heart at the time of retransplantation. Retrospective analysis of potential risk factors for the development of CAD was performed for both immunological (rejection pattern, immunosuppressive therapy, cytomegalovirus [CMV] infection), and nonimmunological (hyperlipidemia, smoking, hypertension, diabetes mellitus, obesity) risk factors. The total number of rejection episodes correlated significantly with the occurrence of CAD (P less than 0.05), showing that patients who experienced two or more rejection episodes had an incidence of CAD of 40%, as opposed to a 23% incidence in patients who experienced no rejection. A composite rejection score derived from multivariate regression analysis of the severity, frequency, and timing of acute cardiac rejection episodes was found to correlate with the development of CAD (P less than 0.05). Postoperative arterial hypertension also correlated significantly with the onset of CAD (P less than 0.01), with a 92.6% incidence of hypertension in the group with CAD versus 76.3% in the group without CAD. Smoking after transplantation correlated significantly with the occurrence of CAD (P less than 0.05). There was no significant correlation with other analyzed factors in this group of patients. In this review, the development of CAD after heart transplantation correlated with treated allograft rejection. Aggressive treatment of hypertension and cessation of smoking may contribute to alleviation of this serious complication.

摘要

同种异体移植冠状动脉疾病(CAD)是心脏移植(HTx)后长期生存的主要决定因素。在一组210例心脏移植受者中,我们通过冠状动脉造影、尸检或再次移植时对移植心脏的检查,在54例(27.1%)患者中诊断出CAD。我们对免疫(排斥模式、免疫抑制治疗、巨细胞病毒[CMV]感染)和非免疫(高脂血症、吸烟、高血压、糖尿病、肥胖)危险因素进行了回顾性分析,以探讨CAD发生的潜在危险因素。排斥发作的总数与CAD的发生显著相关(P<0.05),表明经历两次或更多次排斥发作的患者CAD发生率为40%,而未经历排斥发作的患者CAD发生率为23%。通过对急性心脏排斥发作的严重程度、频率和时间进行多变量回归分析得出的综合排斥评分与CAD的发生相关(P<0.05)。术后动脉高血压也与CAD的发生显著相关(P<0.01),CAD组高血压发生率为92.6%,无CAD组为76.3%。移植后吸烟与CAD的发生显著相关(P<0.05)。在这组患者中,与其他分析因素无显著相关性。在本综述中,心脏移植后CAD的发生与移植心脏排斥反应的治疗情况相关。积极治疗高血压和戒烟可能有助于缓解这一严重并发症。

相似文献

1
Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients.心脏移植受者发生加速性冠状动脉疾病的危险因素。
Eur J Cardiothorac Surg. 1990;4(6):309-12; discussion 313. doi: 10.1016/1010-7940(90)90207-g.
2
Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease.心脏移植术后晚期发生的心脏移植排斥反应是移植后冠状动脉疾病的一个危险因素。
Transplantation. 1998 Feb 27;65(4):538-43. doi: 10.1097/00007890-199802270-00015.
3
Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression.通过增加免疫抑制来降低小儿心脏移植受者冠心病的发病率。
Circulation. 1993 Nov;88(5 Pt 2):II224-9.
4
Low incidence of transplant coronary artery disease in Chinese heart recipients.
J Am Coll Cardiol. 1999 May;33(6):1573-7. doi: 10.1016/s0735-1097(99)00060-1.
5
Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?使用左心室辅助装置过渡到移植是移植冠状动脉疾病的危险因素吗?
J Heart Lung Transplant. 2005 Jun;24(6):703-7. doi: 10.1016/j.healun.2004.03.025.
6
Chronic allograft dysfunction in kidney transplant recipients: long-term single-center study.肾移植受者的慢性移植肾失功:长期单中心研究
Transplant Proc. 2014 Oct;46(8):2673-7. doi: 10.1016/j.transproceed.2014.09.058.
7
Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection.心脏移植受者冠状动脉疾病与巨细胞病毒感染的关联
Am J Cardiol. 1989 Aug 1;64(5):359-62. doi: 10.1016/0002-9149(89)90535-3.
8
Acute rejection and coronary artery disease in long-term survivors of heart transplantation.
J Heart Transplant. 1989 Sep-Oct;8(5):418-20; discussion 420-1.
9
Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.接受他汀类药物治疗的心脏移植受者的生存率、移植血管动脉粥样硬化及排斥反应发生率:5年随访
J Heart Lung Transplant. 2005 Sep;24(9):1235-8. doi: 10.1016/j.healun.2004.08.014.
10
Increased prevalence of autoimmune phenomena and greater risk for alloreactivity in female heart transplant recipients.女性心脏移植受者自身免疫现象的患病率增加以及同种异体反应性风险更高。
Circulation. 2001 Sep 18;104(12 Suppl 1):I177-83. doi: 10.1161/hc37t1.094704.

引用本文的文献

1
Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy.他汀类药物强度对心脏移植血管病变进展的影响。
Card Fail Rev. 2021 Nov 12;7:e15. doi: 10.15420/cfr.2021.07. eCollection 2021 Mar.
2
Listing criteria for heart transplantation in the Netherlands.荷兰心脏移植的列入标准。
Neth Heart J. 2021 Dec;29(12):611-622. doi: 10.1007/s12471-021-01627-x. Epub 2021 Sep 15.
3
Outcomes following cardiac transplantation in adults.成人心脏移植后的结果。
Indian J Thorac Cardiovasc Surg. 2020 Aug;36(Suppl 2):166-174. doi: 10.1007/s12055-019-00796-0. Epub 2019 Feb 15.
4
Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study.心脏移植后治疗性血浆置换的适应证及结果:一项单中心回顾性研究。
J Clin Apher. 2018 Aug;33(4):469-479. doi: 10.1002/jca.21622. Epub 2018 Mar 10.
5
Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis.心脏移植血管病变:诊断、治疗与预后
Croat Med J. 2014 Dec;55(6):562-76. doi: 10.3325/cmj.2014.55.562.
6
Guidelines for heart transplantation.心脏移植指南。
Neth Heart J. 2008;16(3):79-87. doi: 10.1007/BF03086123.
7
Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets.心脏移植血管病变与胰岛素抵抗——新治疗靶点的希望
Endocrinol Metab Clin North Am. 2007 Dec;36(4):965-81; ix. doi: 10.1016/j.ecl.2007.07.012.
8
The challenge of rejection and cardiac allograft vasculopathy.排斥反应和心脏移植血管病变的挑战。
Heart Fail Rev. 2001 Sep;6(3):227-40. doi: 10.1023/a:1011414307636.
9
Update on pediatric heart transplantation. Long-term complications.小儿心脏移植的最新进展。长期并发症。
Tex Heart Inst J. 1997;24(4):260-8.